Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts

Toxicology in Vitro

Volumn 21, Issue 5, 2007, Pages 962-971

  Bigl, Katrin ^a   Schmitt, Annett ^a   Meiners, Ina ^a   Münch, Gerald ^c   Arendt, Thomas ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Advanced glycation endproducts; AGEs; Alamar blue; Cell viability; CellTiter Blue; CTB; Lactate dehydrogenase; LDH; Membrane integrity; MTT; RAGE; Receptor for AGEs; Tetrazolium (3 4,5 dimethylthioazol 2 yl 2,5 diphenyl tetrazolium bromide)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADVANCED GLYCATION END PRODUCT; DYE; GLUCOSE; HUMAN SERUM ALBUMIN; LACTATE DEHYDROGENASE; REAGENT;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ASSAY; GLIA; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NERVE CELL; NONHUMAN;

ANIMALS; BRAIN; CELL COUNT; CELL LINE; CELL SURVIVAL; COLORING AGENTS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INDICATORS AND REAGENTS; L-LACTATE DEHYDROGENASE; MICE; PROTEINS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; TETRAZOLIUM SALTS; THIAZOLES;

EID: 34247156760     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.02.003     Document Type: Article

References (31)

1. Basta G., Schmidt A.M., and De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetis. Cardiovascular Research 63 (2004) 582-592
2. Chibber R., Molinatti P.A., Rosatto N., Lambourne B., and Kohner E.M. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 40 (1997) 156-164
3. Gasic-Milenkovic J., Loske C., Deuther-Conrad W., and Münch G. Protein "AGEing" - cytotoxicity of a glycated protein increases with its degree of AGE-modification. Zeitschrift für Gerontologie und Geriatrie 34 (2001) 1-4
4. Gasic-Milenkovic J., Dukic-Stefanovic S., Deuther-Conrad W., Gärtner U., and Münch G. ß-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-γ and "advanced glycation endproducts" in a murine microglia cell line. European Journal of Neuroscience 17 (2003) 813-821
5. Gonzalez R.J., and Tarloff J.B. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicology in Vitro 15 (2001) 257-259
6. Hamid R., Rotshteyn Y., Rabadi L., Parikh R., and Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicology in Vitro 18 (2004) 703-710
7. Hoffmann S., Friedrichs U., Eichler W., Rosenthal A., and Wiedemann P. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro. Graefe's Archive for Clinical and Experimental Ophthalmology 240 (2002) 996-1002
8. Holst M.C., and Oredsson S.M. Comparison of three cytotoxicity tests in the evaluation of the cyotoxicity of a spermine analogue on human breast cancer cell lines. Toxicology in Vitro 19 (2005) 379-387
9. Jahn B., Stüben A., and Bhakdi S. Colorimetric susceptibility testing for Aspergillus fumigatus: Comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetratzolium bromide and Alamar Blue tests. Journal of Clinical Microbiology August (1996) 2039-2041
10. Janabi N., Peudenier S., Heron B., Ng K.H., and Tardieu M. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV 40 large T antigen. Neuroscience Letters 195 2 (1995) 105-108
11. Kuhla B., Loske C., Garcia de Arriba S., Schinzel R., Huber J., and Münch G. Differential effects of "Advanced Glycation Endproducts" and ß-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y. Journal of Neural Transmission 111 (2004) 427-439
12. Kuhla B., Lüth H.-J., Haferburg D., Boeck K., Arendt T., and Münch G. Methylglyoxal, Glyoxal and their detoxification in Alzheimer's Disease. Annals of the New York Academy of Sciences 1043 (2005) 211-216
13. Kuniyasu H.K., Chiharaa Y., and Kondo H. Differential effects between amphoterin and advanced glycation endproducts on colon cancer cells. International Journal of Cancer 104 6 (2003) 722-727
14. Loske C., Neumann A., Cunningham A.M., Nichol N., Schinzel R., Riederer P., and Münch G. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. Journal of Neural Transmission 105 (1998) 1005-1015
15. Mamputu C., and Renier G. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetis, Obesity & Metabolism 6 (2004) 95-103
16. Moalic S., Liagre B., Corbiére C., Bianchi A., Dauca M., Bordji K., and Beneytout J.L. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Letters 506 (2001) 225-230
17. Montoro E., Lemus D., Echemendia M., Martin A., Portaels F., and Palomino J.C. Comparative evaluation of the nitrate reductions assay, the MTT test and the resazurin microtiter assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy 55 (2005) 500-505
18. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European Journal of Biochemistry 267 17 (2000) 5421-5426
19. Pirami L., Stockinger B., Betz Corradin S., Sironi M., Sassano M., Valsasnini P., Righi M., and Ricciardi-Castagnoli P. Mouse macrophage clones immortalized by retroviruses are functionally heterogeneous. Proceedings of the National Academy of Science of the United States of America 88 September (1991) 7543-7547 Immunology
20. Scheubel R.J., Kahrstedt S., Weber H., Holtz J., Friedrich I., Borgermann J., Silber R.-E., and Simm A. Depression of progenitor cell function by advanced glycation endproducts (AGEs): Potential relevance for impaired angiogenesis in advanced age and diabetis. Experimental Gerontology 41 5 (2006) 540-548
21. Schmitt A., Meiners I., Schmitt J., Nöller J., Ihling C., Münch G., Sinz A., and Nieber K. Two analytical methods to study the interaction of AGEs with cell surface proteins. Journal of Biochemical and Biophysical Methods 65 (2005) 121-136
22. Schmitt A., Schmitt J., Münch G., and Gasic-Milenkovic J. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. Analytical Biochemistry 338 (2005) 201-215
23. Schmitt A., Gasic-Milenkovic J., and Schmitt J. Characterization of advanced glycation end products: Mass changes in correlation to side chain modifications. Analytical Biochemistry 346 (2005) 101-106
24. Schmitt A., Bigl K., Meiners I., and Schmitt J. Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures. Biochemica et Biophysica Acta - Cell Experimental Research 1763 (2006) 927-936
25. Sharma S.D., Pandey B.N., Mishra K.P., and Sivakami S. Amadori product and AGE formation during nonenzymatic glycosylation of bovine serum albumin in vitro. Journal of Biochemistry, Molecular Biology and Biophysics 6 (2002) 233-242
26. Silva R.F.M., Falcão A.S., Fernandes A., Gordo A.C., Brito M.A., and Brites D. Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicology Letters 163 (2006) 1-9
27. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cellular and Molecular Biology (Noisy-le-grand, France) 44 (1998) 1013-1023
28. Thornalley P.J. Methods for studying the binding of advanced glycated proteins to receptors for advanced glycation endproducts (AGE-Receptors). Methods in Molecular Biology 196 (2002) 49-62
29. Thornalley P.J., Argirova M., Ahmed N., Mann V.M., Argirov O., and Dawnay A. Mass spectrometric monitoring of albumin in uremia. Kidney International 58 (2000) 2228-2234
30. Ulrich P., and Cerami A. Protein Glycation, Diabetis and Aging. Recent Progress in Hormone Research 56 (2001) 1-21
31. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. The Journal of Biological Chemistry 269 13 (1994) 9889-9897 Issue of April 1